ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CERIS Expands Services and Rebrands

Rapidly Growing Payment Integrity Firm Offers New Solutions in DRG Validation, Data Mining and More

FORT WORTH, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- CERIS, a CorVel company and a leader in both prepay and post-pay health care claims review, has expanded services and launched a top to bottom rebranding to communicate its enhanced value proposition.

CERIS has been a leader in prepay itemized bill review for three decades. It has expanded its service offerings to add innovative services such as full DRG validation review and a state-of-the-art methodology to perform fair and appropriate out-of-network repricing.

CERIS also performs post-payment itemized bill review, clinical coding reviews, implant reviews, chart to charge reviews and medical implant and transplant reviews. It brings to bear deep data mining and analytical capabilities that allow it to discover savings in 97% of all claims that it reviews. In implant claims alone, it obtains an average savings of 62% over original bills.

The rebranding includes the articulation of a specific purpose for CERIS: To help heal healthcare billing through transparency and integrity. The company’s overall vision is to become a beacon of integrity in the healthcare industry.

“As our company continues to grow, we revisit our mission and purpose so we remain aligned, relevant and authentic to who we are,” said company President, Greg Dorn. “Our commitment is to be proactive in meeting our clients’ emerging needs and steward our identity with integrity. Our goal is to remain a premier payment integrity partner.”

In addition to its rearticulated purpose and vision, CERIS will emphasize to its clients its dedication to accuracy and transparency in healthcare billing. Its client interactions are focused on integrity, reliability, dedication, professionalism and true partnership.

For more information visit www.ceris.com, and follow us on LinkedIn.

About CERiS

CERIS, a leader in both prospective and retrospective claims review and repricing, combines clinical expertise and cost containment solutions to ensure the accuracy and transparency in healthcare payments. Accuracy and validation services include itemization review, DRG validation, facility repricing, contract and policy applications, review of implants and devices, and primary payer cost avoidance. Its proprietary universal chargemaster contains billions of charge items from more than 97% of the nation’s hospitals, helping to ensure the accuracy and objectivity of each claim review.

About CorVel

CorVel Corp. applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. We partner with employers, third-party administrators, insurance companies and government agencies in managing worker’s compensation and health, auto and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com

Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.32
-12.37 (-5.55%)
AAPL  278.03
+2.12 (0.77%)
AMD  208.44
+15.94 (8.28%)
BAC  56.53
+1.59 (2.89%)
GOOG  323.10
-8.23 (-2.48%)
META  661.46
-8.75 (-1.31%)
MSFT  400.78
+7.11 (1.81%)
NVDA  185.41
+13.53 (7.87%)
ORCL  142.82
+6.34 (4.65%)
TSLA  411.11
+13.90 (3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.